Skip to content

Astigmatism Management With Iris-registration Guided Corneal Relaxing Incisions or Toric IOLs During Cataract Surgery

Safety and Efficacy of Astigmatism Correction by Iris-registration Guided Corneal Relaxing Incisions or Toric IOL Implantation During Femtosecond Laser-assisted Cataract Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05561296
Enrollment
50
Registered
2022-09-30
Start date
2022-09-30
Completion date
2023-12-31
Last updated
2022-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism, Cataract

Keywords

corneal relaxing incisions, toric IOL, iris registration, femtosecond laser-assisted cataract surgery

Brief summary

Most of the patients presenting for cataract surgery also have pre-existing corneal astigmatism which if left uncorrected can adversely affect visual and refractive outcomes after cataract surgery. Pre-existing astigmatism at the time of cataract surgery can be corrected by either corneal relaxing incisions or implantation of toric IOLs. While the safety and efficacy of these procedures are well established, there are various challenges associated with these techniques that surgeons need to overcome to achieve good outcomes postoperatively. The use of iris registration technology that automatically compensates for cyclotorsion has the potential to improve the alignment accuracy of CRI or toric IOLs. The Cassini Ambient and Catalys Femtosecond Laser incorporate this technology to help cataract surgeons accurately align toric IOLs on the intended axis of implantation or accurately place CRI on the intended meridian. The present study is aimed at evaluating the efficacy of astigmatism correction during femtosecond laser-assisted cataract surgery with Catalys femtosecond laser. The patients will either undergo iris registration guided CRIs or iris registration guided alignment of toric IOLs.

Detailed description

Surgical correction of astigmatism using corneal relaxing incisions or toric IOLs have been widely adopted to correct pre-existing astigmatism in cataract surgery patients. While the safety and efficacy of these procedures are well established, there are various challenges associated with these techniques that surgeons need to overcome to achieve good outcomes postoperatively; for instance, correction of astigmatism either with corneal relaxing incisions (CRIs) or toric IOLs during cataract surgery requires appropriate pre-operative planning based on corneal curvature measurements, biometry, nomogram/IOL selection, accurate marking for the placement of CRI/implantation of toric IOL on the intended axis, intraoperative alignment, cyclotorsion compensation, and postoperative IOL rotation, etc. The Cassini Ambient and Catalys Femtosecond Laser incorporate this technology to help cataract surgeons accurately align toric IOLs on the intended axis of implantation or accurately place CRI on the intended meridian. This is expected to improve patients' visual functioning and reduce spectacle dependence postoperatively. The Cassini Ambient provides the preoperative anterior and posterior astigmatism with iris registration. The new Catalys Precision Laser System (Johnson & Johnson Vision) with cOS 6.0 software facilitates direct importation of preoperative data from the Cassini via a wireless connection or USB drive, eliminates the need for manual axis marking as it compares the pre- and intra-operative iris anatomy data and compensates for tilt and rotation so that the laser marks are perfectly aligned to the steep meridian and the target axis. Linking preoperative diagnostic information to the laser minimizes data entry and transcription errors. It also eliminates several steps in the planning process for toric IOLs and CRI, thus improving the overall accuracy of the astigmatism correction procedure and reducing chances for error.

Interventions

PROCEDUREFemtosecond laser assisted cataract surgery with astigmatism management

The alignment would be guided by preoperatively obtained iris registration using Cassini Ambient. Patients will undergo femtosecond laser-assisted cataract surgery with Catalys femtosecond laser.

Sponsors

Johnson & Johnson Surgical Vision, Inc.
CollaboratorINDUSTRY
Kenneth J Rosenthal
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This prospective, open-label, single-center, non-randomized, interventional study will include 50 patients who will undergo femtosecond laser-assisted cataract surgery (Catalys) and astigmatism correction by either EyHance toric II IOLs or corneal relaxing incisions and implantation of EyHance IOL. The alignment would be guided by preoperatively obtained iris registration using Cassini Ambient.

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Patients desirous of undergoing cataract surgery. * Pre-existing corneal astigmatism requiring either CRIs or toric IOL implantation. * Patients in whom iris registration link between Cassini Ambient and Catalys femtosecond laser is successful.

Exclusion criteria

Patients will be excluded from participating in the study due to any of the following reasons: * Insufficient pupil dilation to complete Catalys treatment * Clinically significant corneal pathology precluding reliable Cassini topographical measurement of any cause * Preoperative corneal astigmatism greater than 4.00 D, or astigmatism requiring both CRIs and implantation of toric intraocular lens for correction. * Cassini topographical measurement deemed inconsistent with historical topographies and refractive error based on clinical judgment * Visually significant ocular surface disease (OSD) precluding reliable measurements and/or anticipated to affect refractive stability * Lid position abnormalities that may affect vision * Moderate or severe stage glaucoma or optic nerve disease, that would interfere with assessment of or achievement of optimal BCVA * Visually significant macular disease

Design outcomes

Primary

MeasureTime frameDescription
Mean postoperative astigmatismpostoperative 3 monthsMean postoperative astigmatism

Secondary

MeasureTime frameDescription
Mean monocular uncorrected distance visual acuity3 months postoperativelyPostoperative mean monocular uncorrected distance visual acuity
Mean monocular corrected distance visual acuity3 months postoperativelyPostoperative mean monocular corrected distance visual acuity

Other

MeasureTime frameDescription
Percentage of eyes with residual refractive astigmatism within 0.5 Dpostoperative 3 monthsFrequency distribution of postoperative refractive astigmatism
Proportion of eyes with uncorrected distance visual acuity 20/x or betterPostoperative 3 monthsFrequency distribution of the proportion of eyes achieving postoperative uncorrected distance visual acuity 20/x or better
Spherical equivalent refractive accuracy3 months postoperativelyProportion of eyes with postoperative MRSE within 0.50 and 1.00 D

Countries

United States

Contacts

Primary ContactKenneth J Rosenthal, MD
research@eyesurgery.org212 517-4500

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026